A Study of Zevalin and Simultaneous Application of BEAM High-dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Refractory and Relapsed Aggressive Non-Hodgkin Lymphomas (escZ-BEAM)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

ClinicalTrials.gov Identifier:

NCT00521560

First received: August 27, 2007

Last updated: February 13, 2013

Last verified: February 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2012
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)